CONMED Corp. buy Piper Sandler
Start price
01.08.24
/
50%
€61.00
Target price
01.08.25
€74.16
Performance (%)
-26.23%
End price
02.08.25
€45.00
Summary
This prediction ended on 02.08.25 with a price of €45.00. The price of CONMED Corp. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -26.23%. Piper_Sandler has a follow-up prediction for CONMED Corp. where he still thinks CONMED Corp. is a Buy. Dividends of €0.37 are taken into consideration when calculating the performance. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| CONMED Corp. | -10.857% | -10.857% | -53.778% |
| iShares Core DAX® | -1.432% | 0.000% | 12.331% |
| iShares Nasdaq 100 | -0.386% | -0.595% | 4.688% |
| iShares Nikkei 225® | 1.448% | 5.269% | 18.051% |
| iShares S&P 500 | 0.114% | -0.217% | 1.388% |
Comments by Piper_Sandler for this prediction
In the thread CONMED Corp. diskutieren
CONMED Co. (NYSE: CNMD) had its price target lowered by analysts at Piper Sandler from $95.00 to $80.00. They now have an "overweight" rating on the stock.
Ratings data for CNMD provided by MarketBeat
In the thread Trading CONMED Corp.
Die von Piper_Sandler gewählte maximale Laufzeit wurde überschritten